NCT05783830View on ClinicalTrials.gov

Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

April 18, 2020

Study Completion Date

April 18, 2020

Conditions

Cognition DisorderAlzheimer Disease

Interventions

DRUG

ACD856

IV injection 100 mcg

Trial Locations (1)

Unknown

Uppsala University Hospital, Uppsala

Sponsors

Lead Sponsor

AlzeCure Pharma

All Listed Sponsors

lead

AlzeCure Pharma

INDUSTRY

NCT05783830 - Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856 | Biotech Hunter | Biotech Hunter